Harmen van Andel
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- Cancer Cells and Metastasis
- Peptidase Inhibition and Analysis
Papers in ⓘ
-
- Multiple Myeloma Research and Treatments 3
- Oncology 7
- Peptidase Inhibition and Analysis 4
- Cancer Cells and Metastasis 2
- Co-authors
- Marcel Spaargaren (9 shared papers)Steven T. Pals (9 shared papers)Kinga A. Kocemba‐Pilarczyk (5 shared papers)Hans Clevers (4 shared papers)Marie José Kersten (5 shared papers)Sander P.J. Joosten (3 shared papers)Jurrit Zeilstra (2 shared papers)Marc van de Wetering (2 shared papers)
- Journals
- Leukemia (2 papers)Oncogene (2 papers)The Journal of Immunology (1 paper)The Journal of Experimental Medicine (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- NetherlandsPolandCanada
In The Last Decade
Harmen van Andel
11 papers receiving 624 citations
Peers
Comparison fields: 5 of 80
- Hematology 129
- Oncology 210
- Cancer Research 98
- Molecular Biology 433
- Cell Biology 92
Countries citing papers authored by Harmen van Andel
This map shows the geographic impact of Harmen van Andel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harmen van Andel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harmen van Andel more than expected).
Fields of papers citing papers by Harmen van Andel
This network shows the impact of papers produced by Harmen van Andel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harmen van Andel. The network helps show where Harmen van Andel may publish in the future.
Co-authors
The 25 scholars most cited alongside Harmen van Andel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 136 | |
| 2 | 2013 | 112 | |
| 3 | 2017 | 91 | |
| 4 | 2017 | 63 | |
| 5 | 2017 | 47 | |
| 6 | 2016 | 41 | |
| 7 | 2012 | 41 | |
| 8 | 2016 | 40 | |
| 9 | 2013 | 31 | |
| 10 | 2016 | 26 | |
| 11 | 2019 | 2 |
About Harmen van Andel
Harmen van Andel is a scholar working on Hematology, Oncology, Nephrology, Molecular Biology and Hepatology, having authored 11 papers that have together received 630 indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (4 papers), Peptidase Inhibition and Analysis (4 papers), Multiple Myeloma Research and Treatments (3 papers), Neuropeptides and Animal Physiology (2 papers), Cancer Cells and Metastasis (2 papers), Ubiquitin and proteasome pathways (2 papers), Kruppel-like factors research (1 paper) and FOXO transcription factor regulation (1 paper). The work is most often cited by research in Hematology (129 citations), Oncology (210 citations), Cancer Research (98 citations), Molecular Biology (433 citations) and Cell Biology (92 citations). Harmen van Andel has collaborated with scholars based in Netherlands, Poland and Canada. Frequent co-authors include Marcel Spaargaren, Steven T. Pals, Kinga A. Kocemba‐Pilarczyk, Hans Clevers, Marie José Kersten, Sander P.J. Joosten, Jurrit Zeilstra, Marc van de Wetering, Cornelia Tölg and M. Snoek. Their work appears in journals such as Leukemia, Oncogene, The Journal of Immunology, The Journal of Experimental Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.